SLC51A and hepatocellular carcinoma: Although FXR stimulates the expression of OSTα/β in cholestatic rodents and hepatoma cell lines [3, 14], the down-regulation of hepatic OSTα/β mRNA in human obstructive cholestasis was not observed in parallel with the FXR reduction.